State of the Art: Using Natriuretic Peptide Levels in Clinical Practice
Alan S. Maisel(Brigham and Women's Hospital), Eugene Braunwald(Brigham and Women's Hospital), Salvatore Di Somma(Clinique Saint Pierre), John G.F. Cleland(University of Glasgow), Nadia Aspromonte(Agostino Gemelli University Polyclinic), Patrick Jourdain(Délégation Paris 5), Gerasimos Filippatos(University General Hospital Attikon), Marco Tubaro(Ospedale Maggiore), Clyde W. Yancy(Unknown), Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), Anthony N. DeMaria, Marc Vanderhyden(Onze Lieve Vrouwziekenhuis Hospital), Markku S. Nieminen(Cornell University), Gregg C. Fonarow(University of California, Los Angeles), Ulf Dahlström(Linköping University), Alain Cohen‐Solal(Hôpital Lariboisière), Alexandre Mebazaa(Délégation Paris 5), Peter P. Liu(Ontario Institute for Cancer Research), Stefan D. Anker, Kirkwood F. Adams(University of North Carolina at Chapel Hill), Michel Komajda(Inserm), Christian Mueller(Universität Hamburg), Theresa A. McDonagh(Royal Brompton Hospital), Kenneth McDonald(University College Dublin), Roberto Valle(Ospedale di San Donà di Piave), W. Frank Peacock
Cited by 837
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
|Circulation|2014|7.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k